Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,304 | 266 | 97.1% |
| Education | $159.85 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $1,478 | 21 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $264.77 | 6 | $0 (2020) |
| Daiichi Sankyo Inc. | $258.41 | 19 | $0 (2019) |
| Boston Scientific Corporation | $228.01 | 14 | $0 (2022) |
| Egalet US Inc | $204.75 | 19 | $0 (2017) |
| Orthogenrx Inc. | $191.94 | 12 | $0 (2021) |
| Flexion Therapeutics, Inc. | $181.57 | 11 | $0 (2020) |
| Purdue Pharma L.P. | $173.66 | 12 | $0 (2018) |
| PFIZER INC. | $172.12 | 15 | $0 (2020) |
| Kaleo, Inc. | $162.54 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.86 | 7 | Nevro Corp. ($347.73) |
| 2023 | $304.39 | 6 | Nevro Corp. ($252.69) |
| 2022 | $264.47 | 8 | Nevro Corp. ($171.33) |
| 2021 | $370.19 | 17 | Nevro Corp. ($181.68) |
| 2020 | $422.36 | 22 | US WorldMeds, LLC ($51.14) |
| 2019 | $990.88 | 55 | Merz North America, Inc. ($218.39) |
| 2018 | $1,119 | 59 | Nevro Corp. ($270.47) |
| 2017 | $1,570 | 94 | Nevro Corp. ($228.70) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $131.08 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $112.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/08/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: OSTEOARTHRITIS | ||||||
| 03/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Endocrinology | ||||||
| 01/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $104.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/13/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/29/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $102.74 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/26/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/08/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $109.27 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/28/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/13/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $132.93 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/01/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/08/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: Opioid Analgesic | ||||||
| 05/12/2022 | Avanos Medical | GENVISC 850 SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/19/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/25/2022 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Not Applicable | ||||||
| 01/18/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/10/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/16/2021 | Medtronic, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: EndoVenous Therapies | ||||||
| 11/01/2021 | Medtronic, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $136.47 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/07/2021 | BOSTON SCIENTIFIC CORPORATION | WAVEWRITER ALPHA (Device) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,474 | 15,515 | $2.3M | $201,227 |
| 2022 | 27 | 1,222 | 2,103 | $1.9M | $145,634 |
| 2021 | 37 | 2,000 | 10,205 | $4.4M | $553,918 |
| 2020 | 34 | 2,098 | 9,979 | $4.0M | $358,578 |
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 795 | $234,525 | $55,138 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 405 | $170,100 | $39,203 | 23.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 84 | 191 | $129,880 | $15,108 | 11.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 111 | 209 | $215,270 | $12,685 | 5.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 101 | 118 | $298,540 | $8,949 | 3.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 39 | 47 | $198,660 | $8,778 | 4.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 39 | 43 | $32,250 | $8,375 | 26.0% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 23 | 12,937 | $72,857 | $6,699 | 9.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 37 | 57 | $164,450 | $4,831 | 2.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $23,750 | $4,779 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $22,680 | $4,452 | 19.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 55 | $42,900 | $4,287 | 10.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 29 | 36 | $91,080 | $2,873 | 3.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 39 | 49 | $101,940 | $2,801 | 2.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 14 | 16 | $70,600 | $2,771 | 3.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 37 | 57 | $83,200 | $2,740 | 3.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 38 | 51 | $29,580 | $2,496 | 8.4% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 13 | 21 | $63,250 | $2,037 | 3.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $36,540 | $1,924 | 5.3% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 47 | 47 | $22,560 | $1,846 | 8.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 14 | 15 | $40,480 | $1,579 | 3.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 15 | 19 | $62,410 | $1,413 | 2.3% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 13 | 21 | $32,000 | $1,151 | 3.6% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 15 | 18 | $39,160 | $1,136 | 2.9% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 23 | 28 | $7,840 | $895.29 | 11.4% |
About Dr. Anthony Grasso, M.D
Dr. Anthony Grasso, M.D is a Pain Medicine healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295710093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Grasso, M.D has received a total of $5,463 in payments from pharmaceutical and medical device companies, with $422.86 received in 2024. These payments were reported across 268 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,304).
As a Medicare-enrolled provider, Grasso has provided services to 6,794 Medicare beneficiaries, totaling 37,802 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Sports Medicine
- Location Marietta, GA
- Active Since 12/14/2005
- Last Updated 01/06/2016
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1295710093
Products in Payments
- Senza (Device) $600.42
- Senza Spinal Cord Stimulation System (Device) $524.98
- Omnia (Device) $353.01
- XEOMIN (Biological) $264.77
- Zilretta (Drug) $181.57
- GenVisc 850 (Device) $177.32
- LYRICA (Drug) $172.12
- Morphabond ER (Drug) $169.79
- ARYMO ER (Drug) $156.97
- BOTOX (Biological) $152.51
- Evzio (Drug) $122.98
- Amitiza (Drug) $112.29
- AIMOVIG (Biological) $109.70
- LORZONE (Drug) $97.79
- PENNSAID (Drug) $91.67
- Movantik (Drug) $88.62
- ORTHOVISC (Device) $86.57
- RELISTOR (Drug) $79.37
- Xtampza ER (Drug) $72.99
- HYSINGLA ER (Drug) $72.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Marietta
Dr. Arnold Weil, M.d, M.D
Pain Medicine — Payments: $84,567
Donald Taylor, Md, MD
Pain Medicine — Payments: $11,293
Paul Mefferd, D.o, D.O
Pain Medicine — Payments: $4,092
Mr. Marc Kornfield, M.d, M.D
Pain Medicine — Payments: $3,678
Joseph Brown, Md, MD
Pain Medicine — Payments: $2,797
Charles Lee, Md, MD
Pain Medicine — Payments: $2,554